Alison Wall, MS

Research Reports

Factors Associated With Poor Outcomes in Patients who Receive Cancer Directed Therapy at the End of Life

02/15/2022

Megan Wall , MS;

Ila M. Saunders , PharmD, BCOP;

Janine Martino , PharmD, BCOP, APh;

Alison Wall , MS;

Shanna Block , PharmD, BCOP;

Rabia S. Atayee , PharmD, BCPS;

Katherine Medley , PharmD;

Yasmine Anouty , PharmD;

Carolyn Mulroney , MD;

Yasmine Anouty, PharmD, and colleagues discern factors that may be associated with poor outcomes in adult patients who received intravenous cancer-directed therapy in the last 30 days of life.

Yasmine Anouty, PharmD, and...

02/15/2022

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Alison Wall, MS

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products